Refine by
Physiological Parameter Articles & Analysis
9 news found
20 years of experience for a platform already tested, effective, fully integrable with the hospital flow and in continuous evolution. Ab medica starts from the many years of monitoring, developing a Class IIA Medical Device, compliant with the GDPR regulation and easily integrated with public and private information systems. Maia connected care is a modular platform that allows ...
ONCOMFORT, GIGA CONSCIOUSNESS, ISIA LAB AND PILIPILI LAUNCH A CO-CREATION PROJECT WITH SUPPORT OF THE BIOWIN HEALTH CLUSTER FRAMEWORK The project aims at objectivizing Digital Sedation™, paving the way for the first management system for non-pharmacological sedation for use in daily clinical practice. In 2017, Oncomfort created a medical device for Digital Sedation™, a digital ...
BrainScope today announced a new system-wide agreement with Yankee Alliance to make BrainScope’s innovative point-of-care neuro-technology system available to the 18,000 members, including over 5000 outpatient facilities and senior centers, in Yankee Alliance. BrainScope is the only FDA cleared medical device that aids in the objective triage of head injured patients for suspected mild ...
Brain-assessment device innovator BrainScope, and Aon plc (NYSE: AON), a leading global professional services firm, today announced the completion of an intellectual property-based funding arrangement. The funding arrangement provides BrainScope with up to $35 million in capital to fund the full expansion of its commercial activities as well as to develop new clinical applications on its ...
BrainScope today announced the availability of its third groundbreaking FDA-cleared algorithm on the BrainScope device. The Concussion Index is the first physiological marker of concussive injury that aids clinicians in the objective assessment of patients at baseline, point of injury, and through recovery. The Concussion Index adds to the suite of FDA cleared algorithms already available on the ...
Acurable, a fast-growing medical device company, has announced the availability of its first product, AcuPebble SA100, a small wearable device which for the first time enables a fully automated and remote diagnosis of obstructive sleep apnoea (OSA). Traditionally, the diagnosis of OSA has required multiple hospital visits for patients, and doctors have had to manually review and analyse data from ...
The U.S. National Nanotechnology Initiative (NNI) will hold a webinar on June 24, 2020, on “Advances in self-powered wearable sensors: A biofuel-powered electronic skin.” NNI states that the development and commercialization of self-powered, battery-free sensors with wireless capabilities would represent a significant step toward meeting the requirements for next-generation ...
Restech, in its role of technical manager and together with all the partner of the project, successfully concluded the CHROMED trial. With 312 patients enrolled and studied for 9 months by 6 clinical centers in 5 EU Countries, CHROMED has been the largest international multi-center randomized control trial evaluating the effectiveness of an integrated telecare approach for COPD patients based on ...
There is a huge gap between the state of the art of health care, which is available in urban areas and developed countries, and the kind of healthcare services available to the rural population in developing countries. Many people in poorer societies suffer because of unavailability of simple and standard medical facilities and diagnostics. Neurosynaptic Communications plans to bridge this gap ...